Cardiology
AlphaGenome Makes Variant Interpretation Political
Google DeepMind’s AlphaGenome can predict how DNA sequence changes affect gene regulation, giving precision medicine a powerful new research tool, but not yet a shortcut to clinical interpretation.
AI Diagnosis Has Entered the Access Debate
Africa’s Cardiovascular Decade Is a System-Design Problem
Inherited Lipid Screening Becomes Europe’s Prevention Test
ATTR Gene Editing Restarts, But Safety Becomes the Access Question
Routine CT Scans Could Become a Heart Failure Early-Warning System
Risk Prediction Cannot Simply Be Imported From Europe
Personalised Cardiology Needs a Digital Fabric, Not Just More Data
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.